Daniela Furrer
Impact in
-
- HER2/EGFR in Cancer Research
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 13
- HER2/EGFR in Cancer Research 9
- Lung Cancer Research Studies 2
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- Caroline Diorio (11 shared papers)Simon Jacob (11 shared papers)François Sanschagrin (4 shared papers)Louise Provencher (6 shared papers)Chantal D. Caron (3 shared papers)Einas Mohamed Yousef (1 shared paper)David Laperrière (1 shared paper)Sylvie C Mader (1 shared paper)
- Journals
- Anticancer Research (2 papers)The FASEB Journal (2 papers)The Veterinary Journal (2 papers)PLoS ONE (2 papers)Clinical Breast Cancer (1 paper)
- Partner nations
- CanadaSwitzerlandBolivia
In The Last Decade
Daniela Furrer
22 papers receiving 375 citations
Peers
Comparison fields: 5 of 81
- Oncology 123
- Cancer Research 51
- Radiology, Nuclear Medicine and Imaging 63
- Biophysics 14
- Reproductive Medicine 15
Countries citing papers authored by Daniela Furrer
This map shows the geographic impact of Daniela Furrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Furrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Furrer more than expected).
Fields of papers citing papers by Daniela Furrer
This network shows the impact of papers produced by Daniela Furrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Furrer. The network helps show where Daniela Furrer may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniela Furrer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 70 | |
| 2 | 2017 | 66 | |
| 3 | 2013 | 37 | |
| 4 | 2018 | 28 | |
| 5 | 2019 | 21 | |
| 6 | 2020 | 21 | |
| 7 | 2017 | 18 | |
| 8 | 2021 | 17 | |
| 9 | 2010 | 16 | |
| 10 | 2009 | 14 | |
| 11 | 2019 | 13 | |
| 12 | 2021 | 11 | |
| 13 | 2016 | 11 | |
| 14 | 2021 | 9 | |
| 15 | 2017 | 9 | |
| 16 | 2009 | 7 | |
| 17 | 2016 | 6 | |
| 18 | 2022 | 4 | |
| 19 | Validation of EP1 Antibody Clone for Estrogen Receptor Immunohistochemistry for Breast Cancer. | 2016 | 3 |
| 20 | 2021 | 3 |
About Daniela Furrer
Daniela Furrer is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Reproductive Medicine, Endocrinology, Diabetes and Metabolism and Pharmacology, having authored 22 papers that have together received 386 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cannabis and Cannabinoid Research (2 papers), Pancreatic function and diabetes (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Lung Cancer Research Studies (2 papers), Glycosylation and Glycoproteins Research (2 papers) and Diabetes Treatment and Management (2 papers). The work is most often cited by research in Oncology (123 citations), Cancer Research (51 citations), Radiology, Nuclear Medicine and Imaging (63 citations), Biophysics (14 citations) and Reproductive Medicine (15 citations). Daniela Furrer has collaborated with scholars based in Canada, Switzerland and Bolivia. Frequent co-authors include Caroline Diorio, Simon Jacob, François Sanschagrin, Louise Provencher, Chantal D. Caron, Einas Mohamed Yousef, David Laperrière, Sylvie C Mader, Muhammad Ramzan Tahir and Louis Arthur Gaboury. Their work appears in journals such as Anticancer Research, The FASEB Journal, The Veterinary Journal, PLoS ONE and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.